Answers are grounded in this paper and cite their sources.
We investigated the inhibitory potential of both protopanaxadiol (PPD)-and protopanaxatriol (PPT)-type ginsenosides on the activities of six uridine 5'-diphospho-glucuronosyltransferase (UGT) isoforms (1A3, 1A4, 1A4, 1A6, 1A9, and 2B7) in pooled human liver microsomes (HLMs). Ginsenosides inhibited the UGT isoform activities in a structure-dependent manner. For example, PPT-type ginsenosides showed minimal inhibition against the activity of the 6 UGT isoforms tested (IC 50 > 37.1 M). The activities of UGT2B7 and UGT1A9 were inhibited by the PPD-type ginsenoside having two sugar moieties at the carbon-3 position of the ginsenoside structure (e.g., ginsenoside Rg3) and PPD-type ginsenosides having two sugar moieties at the carbon-3 position of ginsenoside regardless of the presence or absence of the sugar group at carbon-20 position of ginsenosides (e.g., ginsenoside Rb1, Rb2, Rd, and Rg3), respectively. These results suggest that ginsenosides have a structure-specific inhibitory effect on UGTs in HLMs.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: